Lillian L Siu

Lillian L Siu, MD, FRCPC

Dr. Lillian Siu is a Senior Staff Physician in the Division of Medical Oncology and Hematology at Princess Margaret Hospital since 1998, and is a Professor of Medicine at the University of Toronto. Dr. Siu is Director of the Phase I Program and Co-Director of the Robert and Maggie Bras and Family Drug Development Program at Princess Margaret Hospital.

Dr. Siu is the recipient of national and international awards such as the Elsie Winifred Crann Award from the University of Toronto in 2001 and the Michaele C. Christian Award in Oncology Drug Development from the US National Cancer Institute in 2010. Internationally, Dr. Siu has been a member of the AACR International Membership Committee, the ASCO Head and Neck Cancer Scientific Program Subcommittee and the EORTC Protocol Review Committee. Dr. Siu was the Neuroendocrine Tumor Task Force Chair in the North American Gastrointestinal Intergroup Scientific Steering Committee from 2007-2009, and she was the ASCO Grants Selection Committee Chair in 2009-10. In 2009, Dr. Siu was awarded a Cancer Care Ontario Tier 1 Chair in Experimental Therapeutics. Dr. Siu has a strong background in clinical trial methodology and has been a member of the Program Committees for the ECCO/ASCO/AACR workshop in Flims, Switzerland and the AACR/ASCO workshop in Vail, Colorado. Dr. Siu has published over 110 peer-reviewed manuscripts, and she is currently on the Editorial Boards of Journal of Clinical Oncology, European Journal of Cancer and Cancer Discovery
Developmental Therapeutics and Phase I Clinical Trials of Novel Agents

Dr. Siu's major research focus is in the area of new anticancer drug development, particularly with respect to phase I trials and head and neck malignancies. She is the principal investigator of a phase I cooperative agreement U01 award (2008-2013) sponsored by the United States National Cancer Institute, which aims to expedite the access and evaluation of novel anti-cancer agents.

Related Links

Breast Cancer Res Treat. 2017 Nov 24;:
Pezo RC, Chen TW, Berman HK, Mulligan AM, Razak AA, Siu LL, Cescon DW, Amir E, Elser C, Warr DG, Sridhar SS, Yu C, Wang L, Stockley TL, Kamel-Reid S, Bedard PL
JAMA Otolaryngol Head Neck Surg. 2017 Nov 22;:
Zer A, Pond GR, Razak ARA, Tirona K, Gan HK, Chen EX, O'Sullivan B, Waldron J, Goldstein DP, Weinreb I, Hope AJ, Kim JJ, Chan KKW, Chan AK, Siu LL, Bernstein LJ
Oncotarget. 2017 Oct 17;8(49):84659-84670
Brana I, Pham NA, Kim L, Sakashita S, Li M, Ng C, Wang Y, Loparco P, Sierra R, Wang L, Clarke BA, Neel BG, Siu LL, Tsao MS
Ann Oncol. 2017 Nov 13;:
Yates LR, Seoane J, Le Tourneau C, Siu LL, Marais R, Michiels S, Soria JC, Campbell P, Normanno N, Scarpa A, Reis-Filho JS, Rodon J, Swanton C, Andre F
Clin Colorectal Cancer. 2017 Oct 23;:
Chiu JW, Krzyzanowska MK, Serra S, Knox JJ, Dhani NC, Mackay H, Hedley D, Moore M, Liu G, Burkes RL, Brezden-Masley C, Roehrl MH, Craddock KJ, Tsao MS, Zhang T, Yu C, Kamel-Reid S, Siu LL, Bedard PL, Chen EX
Target Oncol. 2017 Oct 24;:
Wainberg ZA, Alsina M, Soares HP, Braña I, Britten CD, Del Conte G, Ezeh P, Houk B, Kern KA, Leong S, Pathan N, Pierce KJ, Siu LL, Vermette J, Tabernero J
Br J Cancer. 2017 Oct 24;:
Prawira A, Oosting SF, Chen TW, Delos Santos KA, Saluja R, Wang L, Siu LL, Chan KKW, Hansen AR
J Clin Oncol. 2017 Oct 24;:JCO2017738633
Quon H, Vapiwala N, Forastiere A, Kennedy EB, Adelstein DJ, Boykin H, Califano JA, Holsinger FC, Nussenbaum B, Rosenthal DI, Siu LL, Waldron JN
Ann Oncol. 2017 Oct 01;28(10):2377-2385
Khoja L, Day D, Wei-Wu Chen T, Siu LL, Hansen AR

Pages


 

Professor of Medicine, University of Toronto
Staff Physician, Division of Medical Oncology and Hematology, Princess Margaret Hospital
Director, Phase I Program and Co-Director, Robert and Maggie Bras and Family Drug Development Program, Princess Margaret Hospital